SYNGILVIA
Live / Registered — Cancelled — Section 71 (as of 13 Feb 2026)
What this means for you
Registered since 30 Jul 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79247832
- Registration number
- 5816153
- Mark type
- Stylized text
- Filed
- 30 Oct 2018
- Published for opposition
- 14 May 2019
- Registered
- 30 Jul 2019
- Attorney of record
- Jeannine Rittenhouse
Goods and services
- Class 005 — Pharmaceuticals: Medicines for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases; pharmaceutical products for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases; pharmaceutical preparations for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases; medical preparations for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases; biological preparations for medical use for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases
Owner
Prosecution history
- 13 Feb 2026 — CANCELLED SECTION 71
- 30 Jul 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 06 Dec 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 20 Nov 2019 — FINAL DISPOSITION NOTICE SENT TO IB
- 20 Nov 2019 — FINAL DISPOSITION PROCESSED
- 30 Oct 2019 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 30 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 18 May 2019 — NOTIFICATION PROCESSED BY IB
- 14 May 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 May 2019 — PUBLISHED FOR OPPOSITION
- 01 May 2019 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 01 May 2019 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 24 Apr 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Apr 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Mar 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED